Press Releases + New Year: - Any -2024202320222021202020192018201720162015201420132012201120102009 Items per page 102550 Date Title and Summary View Toggle SummaryOct 03, 2011 Galectin Therapeutics Board Member John Mauldin Plans to Purchase Stock Under 10b5-1 Plan; Company Featured in his e-newsletter "Thoughts from the Frontline" View HTML Galectin Therapeutics Board Member John Mauldin Plans to Purchase Stock Under 10b5-1 Plan; Company Featured in his e-newsletter "Thoughts from the Frontline" 15.6 KB Toggle SummarySep 29, 2011 Galectin Therapeutics Posts New Corporate Presentation Video to its Website Highlights Leadership Position Developing Galectin-Inhibiting Therapeutics to Treat Fibrosis & Cancer View HTML Galectin Therapeutics Posts New Corporate Presentation Video to its Website 16.1 KB Toggle SummarySep 07, 2011 Galectin Therapeutics to Present Corporate Update at the Rodman & Renshaw HealthcareConference View HTML Galectin Therapeutics to Present Corporate Update at the Rodman & Renshaw HealthcareConference 16.6 KB Toggle SummaryAug 12, 2011 Galectin Therapeutics Reports Financial Results for Second Quarter 2011 View HTML Galectin Therapeutics Reports Financial Results for Second Quarter 2011 18.1 KB Toggle SummaryAug 05, 2011 10X Fund Issues Statement Regarding Investment in Galectin Therapeutics View HTML 10X Fund Issues Statement Regarding Investment in Galectin Therapeutics 18.2 KB Toggle SummaryJul 21, 2011 Galectin Therapeutics Announces Research Collaboration with Dr. Jose Jalife of the University of Michigan Medical School to Explore Role of Galectins in Cardiovascular Disease View HTML Galectin Therapeutics Announces Research Collaboration with Dr. Jose Jalife of the University of Michigan Medical School to Explore Role of Galectins in Cardiovascular Disease 16.7 KB Toggle SummaryJun 15, 2011 ADDING and REPLACING Galectin Therapeutics Announces New Stock Trading Symbol "GALT" View HTML ADDING and REPLACING Galectin Therapeutics Announces New Stock Trading Symbol "GALT" 13.4 KB Toggle SummaryJun 14, 2011 Galectin Therapeutics Expands European Patent Coverage Patent Covers Use of GM-CT-01 with Chemotherapy to Increase Effectiveness and Reduce Side Effects of Cancer Treatments View HTML Galectin Therapeutics Expands European Patent Coverage 18.4 KB Toggle SummaryJun 09, 2011 Galectin Therapeutics to Present Corporate Update at NIBA Conference View HTML Galectin Therapeutics to Present Corporate Update at NIBA Conference 16 KB Toggle SummaryJun 02, 2011 Galectin Therapeutics Announces the Appointment of Kevin Freeman and John Mauldin to the Board of Directors View HTML Galectin Therapeutics Announces the Appointment of Kevin Freeman and John Mauldin to the Board of Directors 18.3 KB Pagination First page First Previous page Previous … Page 31 Current page 32 Page 33 Page 34 … Next page Next Last page Last
Galectin Therapeutics Board Member John Mauldin Plans to Purchase Stock Under 10b5-1 Plan; Company Featured in his e-newsletter "Thoughts from the Frontline" 15.6 KB
Galectin Therapeutics to Present Corporate Update at the Rodman & Renshaw HealthcareConference 16.6 KB
Galectin Therapeutics Announces Research Collaboration with Dr. Jose Jalife of the University of Michigan Medical School to Explore Role of Galectins in Cardiovascular Disease 16.7 KB
Galectin Therapeutics Announces the Appointment of Kevin Freeman and John Mauldin to the Board of Directors 18.3 KB
